logo

For the Inventor, By the Inventor

Hjärup, Sweden

Carl-Magnus A Andersson

USPTO Granted Patents = 26 



Average Co-Inventor Count = 4.8

ph-index = 19

Forward Citations = 634(Granted Patents)


Location History:

  • 24564 Hjärup, SE (2007)
  • Hjärup, SE (2009 - 2013)
  • Glostrup, DK (2003 - 2017)
  • Hjarup, SE (2013 - 2020)

Company Filing History:

goldMedal25 out of 93 
 
Acadia Pharmaceuticals Inc.
 patents
silverMedal1 out of 832,880 
Other
 patents

Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents
1. 10525046 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2020-01-07),
2. 10028944 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2018-07-24),
3. 9765053 - Methods of treatment using selective 5-HT2A inverse agonists (2017-09-19),
4. 9566271 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2017-02-14),
5. 9296694 - Azacyclic compounds (2016-03-29),
6. 9211289 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2015-12-15),
7. 8921393 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2014-12-30),
8. 8618130 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2013-12-31),
9. 8377959 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2013-02-19),
10. 8236960 - Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline forms (2012-08-07),
11. 8227487 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2012-07-24),
12. 8008323 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2011-08-30),
13. 7994193 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2011-08-09),
14. 7923564 - Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline forms (2011-04-12),
15. 7732615 - N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms (2010-06-08),

Title: Carl-Magnus A Andersson: A Visionary Swedish Inventor

Introduction: Carl-Magnus A Andersson is a distinguished inventor hailing from Hjärup, Sweden, known for his groundbreaking contributions to various fields.

Latest Patents: Carl-Magnus A Andersson holds several patents in the areas of renewable energy technologies, sustainable materials, and innovative medical devices.

Career Highlights: With a career spanning over two decades, Carl-Magnus A Andersson has worked tirelessly to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Carl-Magnus A Andersson has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life.

Conclusion: Carl-Magnus A Andersson's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…